Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Arcellx raises $124M in Wall Street debut to bankroll study of multiple myeloma CAR-T
Nia JulianFebruary 8, 2022
Facebook0 Twitter Pinterest0 0 Likes
Previous

ASCO: ‘Any way you slice’ it, Arcellx's CAR-T is matching J&J-Legend’s Carvykti, analyst says

Nia JulianJune 9, 2022
Next

Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology

Nia JulianJanuary 11, 2022

© 2020 Solasta Ventures. All Rights Reserved.